MARKET

TLGT

TLGT

Teligent Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4951
-0.0049
-0.98%
After Hours: 0.4951 0 0.00% 18:19 05/13 EDT
OPEN
0.4998
PREV CLOSE
0.5000
HIGH
0.5172
LOW
0.4750
VOLUME
1.62M
TURNOVER
--
52 WEEK HIGH
5.94
52 WEEK LOW
0.4550
MARKET CAP
45.95M
P/E (TTM)
-0.0575
1D
5D
1M
3M
1Y
5Y
26 Stocks Moving in Thursday's Pre-Market Session
Gainers Fuel Tech, Inc. (NASDAQ: FTEK) shares rose 26.3% to $2.45 in pre-market trading after the company reported upbeat results for its first quarter on Wednesday.
Benzinga · 20h ago
Atropine Sulfate Market Growth, Application, Segmentation and Forecast to 2028
May 12, 2021 (AmericaNewsHour) -- Research Nester released a report titled “Atropine Sulfate Market – Global Demand Analysis & Opportunity Outlook 2028″...
AmericaNewsHour · 1d ago
Lidocaine Ointment Market Size 2021: Impact of Covid-19 on Industry Share, CAGR Value, Latest Trends, Top Leading Players, Applications, and Global Forecast to 2027
The Express Wire · 1d ago
Cefuroxime Sodium Injection Market Analysis, Trends and CAGR Projections 2021-2027
May 12, 2021 (Market Stats News via COMTEX) -- Market Survey: COVID-19 can affect the global economy in three main ways: by directly affecting production and...
Market Stats News · 1d ago
Econazole Nitrate Cream Market Growth, Share, 2021 Global Industry Trends, Size, Revenue, CAGR Status, Business Opportunities and Demand Forecast to 2027
May 07, 2021 (The Expresswire) -- Global "Econazole Nitrate Cream Market" (2021) analyzes the impact of various Factors influencing the market improvement...
The Express Wire · 6d ago
Lidocaine Market Research Insights, Business Opportunities,Competitive Landscape and Growth Trends
May 06, 2021 (Heraldkeepers) -- Global Lidocaine Market: Information by Formulation (Injections, Creams, Ointments, Gels, Aerosol Liquids and others), by...
Heraldkeepers · 05/06 16:37
Lidocaine Market Share 2020, Global Size Estimation, Growth, SWOT Analysis 2027
May 06, 2021 (Heraldkeepers) -- Global Lidocaine Market: Information by Formulation (Injections, Creams, Ointments, Gels, Aerosol Liquids and others), by...
Heraldkeepers · 05/06 15:32
Pelvic Inflammatory Disease Therapeutics Market Size, Demand-sales, Suppliers By Key Applications Detailed Analysis and Growth Aspects on Manufacturing Landscapes
Japan, Japan, Thu, 06 May 2021 07:58:49 / Comserve Inc. / -- The report analyze market size, share, growth, trends, segmentation, top key players,...
Comserve · 05/06 14:55
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TLGT. Analyze the recent business situations of Teligent Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TLGT stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 73
Institutional Holdings: 14.36M
% Owned: 15.47%
Shares Outstanding: 92.82M
TypeInstitutionsShares
Increased
4
359.94K
New
0
0
Decreased
0
0
Sold Out
1
500
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.01%
Pharmaceuticals & Medical Research
+0.65%
Key Executives
Chairman/Director
John Celentano
President/Chief Executive Officer/Director
Timothy Sawyer
Chief Financial Officer
Ernest De Paolantonio
Executive Vice President/Secretary
Philip Yachmetz
Director
William Marth
Director
Carter Pate
Independent Director
Carole Ben-Maimon
Independent Director
Bhaskar Chaudhuri
Independent Director
Steven Koehler
Independent Director
Thomas Sabatino
No Data
About TLGT
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.

Webull offers kinds of Teligent Inc (NEW JERSEY) stock information, including NASDAQ:TLGT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLGT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TLGT stock methods without spending real money on the virtual paper trading platform.